Active	Status	Sponsor type	Region	Phase	Filter
16 Active 1 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

16 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kohl, Zacharias
NfL-ALS, NCT06201650: Neurofilament Light Chain in Amyotrophic Lateral Sclerosis	Recruiting	N/A	3000	Europe	Neurofilament light chain	Charite University, Berlin, Germany, Boris Canessa ALS Stiftung	Amyotrophic Lateral Sclerosis, Motor Neuron Disease	12/24	12/24
LIPCAL-ALS II, NCT06280079: Ultra-high-caloric, Fatty Diet in ALS	Recruiting	N/A	392	Europe	Ultra-high-caloric fatty diet, Placebo	University of Ulm	Amyotrophic Lateral Sclerosis	06/27	06/27
HSP-PBP, NCT03981276: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders	Recruiting	N/A	2000	Europe	Clinical rating scale to measure disease severity and progression, Spastic Paraplegia Rating Scale (SPRS), Next-Gen Sequencing (NGS)	Dr. Rebecca Schule, German Federal Ministry of Education and Research, German Center for Neurodegenerative Diseases (DZNE)	Hereditary Spastic Paraplegia	08/39	08/41
Mestre, Tiago
MDC-CAN-PD, NCT03639064: Cannabis Oil for Pain in Parkinson's Disease	Recruiting	2	15	Canada	Cannabis Oil	University Health Network, Toronto, Parkinson Society Canada	Parkinson Disease	12/22	12/22
NCT05032196: Study of WVE-003 in Patients With Huntington's Disease	Completed	1/2	47	Europe, Canada, RoW	WVE-003	Wave Life Sciences Ltd.	Huntington Disease	05/24	05/24
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease	Recruiting	N/A	2500	Europe, Canada, US, RoW		University College, London, CHDI Foundation, Inc.	Huntington's Disease	05/25	05/25
PPMI, NCT04477785: Clinical - Establishing a Deeply Phenotyped PD Cohort	Recruiting	N/A	4500	Europe, Canada, US, RoW		Michael J. Fox Foundation for Parkinson's Research, Institute for Neurodegenerative Disorders	Parkinson Disease	12/33	12/33
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort	Recruiting	N/A	35000	Europe, Canada, US, RoW		CHDI Foundation, Inc.	Huntington's Disease	01/62	01/62
Seifert, Susanne
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease	Recruiting	N/A	2500	Europe, Canada, US, RoW		University College, London, CHDI Foundation, Inc.	Huntington's Disease	05/25	05/25
HSP-PBP, NCT03981276: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders	Recruiting	N/A	2000	Europe	Clinical rating scale to measure disease severity and progression, Spastic Paraplegia Rating Scale (SPRS), Next-Gen Sequencing (NGS)	Dr. Rebecca Schule, German Federal Ministry of Education and Research, German Center for Neurodegenerative Diseases (DZNE)	Hereditary Spastic Paraplegia	08/39	08/41
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort	Recruiting	N/A	35000	Europe, Canada, US, RoW		CHDI Foundation, Inc.	Huntington's Disease	01/62	01/62
Jurgen, Winkler
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease	Recruiting	N/A	2500	Europe, Canada, US, RoW		University College, London, CHDI Foundation, Inc.	Huntington's Disease	05/25	05/25
Pryssok, Pia-Marie
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease	Recruiting	N/A	2500	Europe, Canada, US, RoW		University College, London, CHDI Foundation, Inc.	Huntington's Disease	05/25	05/25
Ding, Jane
NCT03306979: Memory and Antioxidants in Vascular Impairment Trial	Completed	2	60	Canada	N Acetylcysteine, NPN 80004844, Placebo oral capsule, Placebo	Sunnybrook Health Sciences Centre	Vascular Cognitive Impairment no Dementia	09/23	09/23
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease	Recruiting	N/A	2500	Europe, Canada, US, RoW		University College, London, CHDI Foundation, Inc.	Huntington's Disease	05/25	05/25
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort	Recruiting	N/A	35000	Europe, Canada, US, RoW		CHDI Foundation, Inc.	Huntington's Disease	01/62	01/62